摘要 |
This invention is directed to pyridopyrimidinone compounds of formula (I): wherein n, R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
|